A double-tracer technique to characterize absorption, distribution, metabolism and excretion (ADME) of [14C]-basimglurant and absolute bioavailability after oral administration and concomitant intravenous microdose administration of [13C6]-labeled basimglurant in humans
Author:
Affiliation:
1. Roche Pharmaceutical Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland and
2. Roche Pharmaceutical Research and Early Development, Roche Innovation Center NYC, NY, USA
Publisher
Informa UK Limited
Subject
Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine
Link
https://www.tandfonline.com/doi/pdf/10.3109/00498254.2016.1169334
Reference21 articles.
1. A randomized clinical trial of repetitive transcranial magnetic stimulation in the treatment of major depression
2. mGlu2/3 and mGlu5 receptors: Potential targets for novel antidepressants
3. Emerging drugs for major depressive disorder
4. Signaling pathways underlying the rapid antidepressant actions of ketamine
5. Practical experience of using human microdosing with AMS analysis to obtain early human drug metabolism and PK data
Cited by 16 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The application of Phase 0 and microtracer approaches in early clinical development: past, present, and future;Frontiers in Pharmacology;2024-03-18
2. Non‐Labeled, Stable Labeled, or Radiolabelled Approaches for Provision of Intravenous Pharmacokinetics in Humans: A Discussion Piece;Clinical Pharmacology & Therapeutics;2023-12-22
3. Design, conduct, and interpretation of human mass balance studies and strategies for assessing metabolites-in-safety testing (MIST) in drug development;Overcoming Obstacles in Drug Discovery and Development;2023
4. Clinical Pharmacokinetics of Daprodustat: Results of an Absorption, Distribution, and Excretion Study With Intravenous Microtracer and Concomitant Oral Doses for Bioavailability Determination;Clinical Pharmacology in Drug Development;2021-10-28
5. Modulating Neuroplasticity: Lessons Learned from Antidepressants and Emerging Novel Therapeutics;Current Treatment Options in Psychiatry;2021-10-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3